Table A.14

Warning View the most recent version.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.


Table A.14
Percentage of bioproduct establishments with in-house research and experimental development (R&D) expenditures in Canada in 2015, by region and establishment size, 2015
Table summary
This table displays the results of Percentage of bioproduct establishments with in-house research and experimental development (R&D) expenditures in Canada in 2015. The information is grouped by Region (appearing as row headers), In-house research and experimental development (R&D) and No In-house research and experimental development (R&D), calculated using percent (%) units of measure (appearing as column headers).
Region In-house research and experimental development (R&D) No In-house research and experimental development (R&D)
percent (%)
Canada 56.5Table A.14 Note B 43.5Table A.14 Note B
Atlantic provinces 52.6Note E: Use with caution 47.4Note E: Use with caution
Quebec 59.7Table A.14 Note C 40.3Table A.14 Note C
Ontario 51.9Table A.14 Note D 48.1Table A.14 Note D
Prairies 50.0Table A.14 Note D 50.0Table A.14 Note D
British Columbia 75.9Table A.14 Note C 24.1Table A.14 Note C
Size
Small (less than 50 employees) 57.7Table A.14 Note B 42.3Table A.14 Note B
Medium (50 to 149 employees) 64.1Note E: Use with caution 35.9Note E: Use with caution
Large (more than 149 employees) 44.1Table A.14 Note D 55.9Table A.14 Note D
Date modified: